Improving DEtection of Atrial fibriLlation in Primary Care With the MyDiagnostick

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 16000 participants.

Also called NCT02270151

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose screening
Phase
Phase 3
Enrolled
  • 16,000 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02270151
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Netherlands (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02270151. Randomized; no masking; primary purpose screening. Start 2014-11 (registry gives no type); primary completion 2016-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Improving DEtection of Atrial fibriLlation in Primary Care With the MyDiagnostick
Acronym
IDEAL-MD
Intervention (Device)
MyDiagnostick
Lead sponsor
UMC Utrecht (class: other)
Collaborator
Boehringer Ingelheim (class: industry)

Record details

Record id
cardio:ct-nct02270151
Content hash
799672fec01a1bc66539a406a59f4d8d593294f1d789f0b17356a8fb284f1d43